Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 219, Issue 1-2, 2010, Pages 47-53

  Begum Haque, Sakhina ^a,b   Sharma, Alok ^a,b   Christy, Marc ^a,b   Lentini, Tim ^a,b   Ochoa Reparaz, Javier ^a,b   Fayed, Islam F ^a,b   Mielcarz, Daniel ^a,b   Haque, Azizul ^a,b,c   Kasper, Lloyd H ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH COLLEGE   (United States)

^c University Lille   (France)

Author keywords

A proliferation inducing ligand (APRIL); B cell activating factor (BAFF); Experimental autoimmune encephalomyelitis (EAE); Glatiramer Acetate (GA); IL 13 production

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CD19 ANTIGEN; CD5 ANTIGEN; GLATIRAMER; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 19; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD19; ANTIGENS, CD5; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; BRAIN; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLYCOPROTEINS; IMMUNOSUPPRESSIVE AGENTS; LYMPH NODES; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PEPTIDES; RNA, MESSENGER; SPLEEN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 77249142775     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.11.016     Document Type: Article

References (50)

1. Aharoni R., Teitelbaum D., Arnon R., Sela M. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:634-639.
2. Arnon R., Aharoni R. Neurogenesis and neuroprotection in the CNS-fundamental elements in the effect of glatiramer acetate on treatment of autoimmune neurological disorders. Mol. Neurobiol. 2007, 36:245-253.
3. Arnon R., Sela M. Immunomodulation by the copolymer glatiramer acetate. J. Mol. Recognit. 2003, 16:412-421.
4. Begum-Haque S., Sharma A., Kasper I.R., Foureau D.M., Mielcarz D.W., Haque A., Kasper L.H. Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2008, 204:58-65.
5. Bettelli E., Baeten D., Jager A., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 2006, 116:2393-2402.
6. Bouaziz J.D., Yanaba K., Venturi G.M., Wang Y., Tisch R.M., Poe J.C., Tedder T.F. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20878-20883.
7. Chan O.T., Shlomchik M.J. Cutting edge: B cells promote CD8+ T cell activation in MRL-Fas(lpr) mice independently of MHC class I antigen presentation. J. Immunol. 2000, 164:1658-1662.
8. Chan O.T., Hannum L.G., Haberman A.M., Madaio M.P., Shlomchik M.J. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 1999, 189:1639-1648.
9. Chan O.T., Madaio M.P., Shlomchik M.J. The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 1999, 169:107-121.
10. Chu V.T., Enghard P., Riemekasten G., Berek C. In vitro and in vivo activation induces BAFF and APRIL expression in B cells. J. Immunol. 2007, 179:5947-5957.
11. Crawford A., Macleod M., Schumacher T., Corlett L., Gray D. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J. Immunol. 2006, 176:3498-3506.
12. Dalakas M.C. Invited article: inhibition of B cell functions: implications for neurology. Neurology 2008, 70:2252-2260.
13. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002, 3:944-950.
14. Gandhi K.S., McKay F.C., Schibeci S.D., Arthur J.W., Heard R.N., Stewart G.J., Booth D.R. BAFF is a biological response marker to IFN-beta treatment in multiple sclerosis. J. Interferon. Cytokine. Res. 2008, 28:529-539.
15. Huntington N.D., Tomioka R., Clavarino C., Chow A.M., Linares D., Mana P., Rossjohn J., Cachero T.G., Qian F., Kalled S.L., Bernard C.C., Reid H.H. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses. Int. Immunol. 2006, 18:1473-1485.
16. Jee Y., Piao W.H., Liu R., Bai X.F., Rhodes S., Rodebaugh R., Campagnolo D.I., Shi F.D., Vollmer T.L. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin. Immunol. 2007, 125:34-42.
17. Kasper L.H., Haque A., Haque S. Regulatory mechanisms of the immune system in multiple sclerosis. T regulatory cells: turned on to turn off. J. Neurol. 2007, 245S:10-14.
18. Kern C., Cornuel J.F., Billard C., Tang R., Rouillard D., Stenou V., Defrance T., Ajchenbaum-Cymbalista F., Simonin P.Y., Feldblum S., Kolb J.P. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004, 103:679-688.
19. Krishnamoorthy G., Lassmann H., Wekerle H., Holz A. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 2006, 116:2385-2392.
20. Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader F., Monoranu C.M., Kalled S.L., Hess D.M., Serafini B., Aloisi F., Wekerle H., Hohlfeld R., Meinl E. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 2005, 201:195-200.
21. Krumbholz M., Faber H., Steinmeyer F., Hoffmann L.A., Kumpfel T., Pellkofer H., Derfuss T., Ionescu C., Starck M., Hafner C., Hohlfeld R., Meinl E. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity. Brain 2008, 131:1455-1463.
22. Kuchroo V.K., Martin C.A., Greer J.M., Ju S.T., Sobel R.A., Dorf M.E. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 1993, 151:4371-4382.
23. Mackay F., Sierro F., Grey S.T., Gordon T.P. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr. Dir. Autoimmun. 2005, 8:243-265.
24. Magliozzi R., Columba-Cabezas S., Serafini B., Aloisi F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2004, 148:11-23.
25. Matsushita T., Fujimoto M., Hasegawa M., Komura K., Takehara K., Tedder T.F., Sato S. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am. J. Pathol. 2006, 168:812-821.
26. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 2008, 118:3420-3430.
27. Meinl E., Krumbholz M., Derfuss T., Junker A., Hohlfeld R. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis. J. Neurol. Sci. 2008, 274:42-44.
28. Menard L.C., Minns L.A., Darche S., Mielcarz D.W., Foureau D.M., Roos D., Dzierszinski F., Kasper L.H., Buzoni-Gatel D. B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism. J. Immunol. 2007, 179:4857-4866.
29. Minns L.A., Menard L.C., Foureau D.M., Darche S., Ronet C., Mielcarz D.W., Buzoni-Gatel D., Kasper L.H. TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. J. Immunol. 2006, 176:7589-7597.
30. Ng L.G., Mackay C.R., Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol. Immunol. 2005, 42:763-772.
31. Ochoa-Reparaz J., Rynda A., Ascon M.A., Yang X., Kochetkova I., Riccardi C., Callis G., Trunkle T., Pascual D.W. IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J. Immunol. 2008, 181:954-968.
32. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 1995, 144:245-268.
33. O'Neill S.K., Shlomchik M.J., Glant T.T., Cao Y., Doodes P.D., Finnegan A. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J. Immunol. 2005, 174:3781-3788.
34. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
35. Patke A., Mecklenbrauker I., Tarakhovsky A. Survival signaling in resting B cells. Curr. Opin. Immunol. 2004, 16:251-255.
36. Rahman Z.S., Rao S.P., Kalled S.L., Manser T. Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J. Exp. Med. 2003, 198:1157-1169.
37. Raine C.S. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 1994, 36:S61-72. Suppl.
38. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., Frew E., Scott M.L. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001, 293:2111-2114.
39. Schrempf W., Ziemssen T. Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun. Rev. 2007, 6:469-475.
40. Sutherland A.P., Ng L.G., Fletcher C.A., Shum B., Newton R.A., Grey S.T., Rolph M.S., Mackay F., Mackay C.R. BAFF augments certain Th1-associated inflammatory responses. J. Immunol. 2005, 174:5537-5544.
41. Thangarajh M., Masterman T., Rot U., Duvefelt K., Brynedal B., Karrenbauer V.D., Hillert J. Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis. J. Neuroimmunol. 2005, 167:210-214.
42. Thangarajh M., Masterman T., Hillert J., Moerk S., Jonsson R. A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis. Scand. J. Immunol. 2007, 65:92-98.
43. Varfolomeev E., Kischkel F., Martin F., Seshasayee D., Wang H., Lawrence D., Olsson C., Tom L., Erickson S., French D., Schow P., Grewal I.S., Ashkenazi A. APRIL-deficient mice have normal immune system development. Mol. Cell. Biol. 2004, 24:997-1006.
44. Weber M.S., Prod'homme T., Youssef S., Dunn S.E., Rundle C.D., Lee L., Patarroyo J.C., Stuve O., Sobel R.A., Steinman L., Zamvil S.S. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat. Med. 2007, 13:935-943.
45. Wiesemann E., Klatt J., Sonmez D., Blasczyk R., Heidenreich F., Windhagen A. Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells. J. Neuroimmunol. 2001, 119:137-144.
46. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 1996, 184:2271-2278.
47. Wynn T.A. IL-13 effector functions. Annu. Rev. Immunol. 2003, 21:425-456.
48. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
49. Yang M., Hase H., Legarda-Addison D., Varughese L., Seed B., Ting A.T. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J. Immunol. 2005, 175:2814-2824.
50. Young D.A., Lowe L.D., Booth S.S., Whitters M.J., Nicholson L., Kuchroo V.K., Collins M. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J. Immunol. 2000, 164:3563-3572.